This clinical trial will be conducted to determine the effect of supplemental oxygen administration on nausea and vomiting, in patients undergoing elective cesarean section. 120 patients will be randomly assigned in study groups. Inclusion criteria will be elective cesarean section and fasting for 6-8 hours before and 6 hours after surgery and patients who need to general anesthesia or having sever vomiting, symptomatic gastrointestinal disease, motion sickness, dizziness, heart disease, cardiovascular and pulmonary disease, middle ear diseases, diabetes mellitus, infectious disease, fever, hypertension, smoking, alcohol consumption, immunosuppressive medications, bleeding and hemoglobin less than 10 mg/dl will be excluded. In control group patients will receive 3-5 liters per minute by oxygen masks, but in the intervention group during and after surgery and in recovery for 6 hours 10 liters per minute oxygen through masks will be given. The data collection tools are check list and questionnaire. Total incidence of nausea and vomiting and its severity according to VAS standard tools will be compared in study groups.